Shares of Hims & Hers have been on a wild ride recently. After a strong earnings report on Monday, the stock surged, only to sharply decline before rebounding again later on Tuesday morning. What’s ...

While net income remains relatively thin, the business is scaling efficientlyand doing so across a growing number of ...

Hims & Hers beat first-quarter profit and revenue forecasts as sales more than doubled. However, the health and wellness ...

Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the ...

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

Palantir's revenues rose 39% from $634.3 million in the year-ago quarter. Net income grew to about $214 million, or 8 cents ...

The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...

Matt Britzman, senior equity analyst at Hargreaves Lansdown, said: "Palantir ( PLTR) delivered a knockout quarter by most standards, but shares are still down over 9% in after-hours trading – a clear ...

Explore Hims & Hers' impressive Q1 2025 growth with 111% revenue increase, strategic partnerships, and innovative healthcare solutions.